Session Title: Cataract II
Session Date/Time: Sunday 05/02/2012 | 08:30-11:00
Paper Time: 09:52
Venue: Grand Ballroom
First Author: : P.Schraepen BELGIUM
Co Author(s): : E. Mertens
Purpose:
To evaluate the clinical performance, efficacy and safety and to study the implantation technique of a trifocal IOL (Fine Vision).
Setting:
Medipolis, Antwerp Health Centre, Antwerp, Belgium
Methods:
Retrospective observational study. 60 eyes of 30 patients with cataract or presbyopia, no ocular or systemic comorbidity and no more than 1.50 diopters of preoperative corneal astigmatism underwent phacoemulsification and implantation of a trifocal IOL. Targeted refraction was emmetropia for all cases. Uncorrected visual acuity (UCVA), best corrected distance visual acuity (CDVA), intermediate and near vision (35 and 70 cm) with the best distance correction, residual refractive spherical equivalent, were evaluated one day (for far vision), one week, one month, 3 months and 6 months postoperatively. RESULTS After 3 and 6 months, all eyes obtained a UCVA of 20/30 or better. All eyes had binocular vision at 40 cm higher than 20/25. The intermediate vision was better than 20/25 with the best distance correction for pupil lower than 4.5 mm in photopic conditions. The improvement of the near and intermediate vision was simultaneous with the far vision and with the corneal edema disparition at the slit lamp. No complaints of excessive halos or glare were reported.
Conclusions:
Trifocal IOL implantation after phacoemulsification was a safe and effective method for pseudophakic presbyopia correction in patients at all distances.
Financial Disclosure:
No
